{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigjt7zf6sx47smoj6jbhgzlmhvuaddyzapppptlj3mci3e47cd4ja",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3mlltxmpl7be2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiehsg65m5o7gjcenjb26wgxqjthzqavkybooojroywi3fl7qqwnfy"
    },
    "mimeType": "image/jpeg",
    "size": 418997
  },
  "path": "/2026/05/11/health/hiv-infusion-immunotherapy.html",
  "publishedAt": "2026-05-11T15:11:13.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Acquired Immune Deficiency Syndrome",
    "Immunotherapy",
    "Immune System",
    "Cancer",
    "Research",
    "Genetic Engineering",
    "Blood",
    "University of California, San Francisco",
    "Innovation",
    "Caring Cross"
  ],
  "textContent": "A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood cancers.",
  "title": "A Single Infusion Could Suppress H.I.V. for Years, Study Suggests"
}